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Abstract: Most of statistical approaches in cardiovascular research were based on 
variance analysis (ANOVA). However, most of the time, the assumption that data are
independent is violated since several measures are performed on the same subject (repeated 
measures). In addition, the presence of intra- and inter-observers variability can potentially 
obscure significant differences. 
The linear mixed model (LMM) is an extended multivariate linear regression method of 
analysis that accounts for both fixed and random effects. LMM allows for addressing incomplete
design cases. 
In this paper, LMM was applied to two sets of cardiovascular research data and 
compared to ANOVA. The first example is an analysis of heart rate in mice after atropine and 
propranolol injections. LMM shows an important mouse random effects that depends on 
pharmacological treatment and provides with accurate estimates for each significant experimental 
factors. When randomly suppressing observations from the data sets (20-30%) the time factor of 
Anova model becomes non significant while LMM still remains significant. The second exa mple
is the analysis of isolated coronary-perfused pressure of transgenic mice hearts. LMM
evidenced a significant transgenic effect in both male and female animals, while, with ANOVA, 
the transgenic effects was limited to male mice only. 
In both cases, as compared to ANOVA, the LMM separately accounts for fixed and 
random effects, allowing thus for studying more adequately incomplete designs on repeated 
measures.
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Modélisation de Données Cardiovasculaires.
Une Introduction aux Modèles Linéaires Mixtes
Résumé: La plupart des études statistiques faites dans le domaine cardio-vasculaire
sont basées sur l’analyse de la variance (ANOVA). Cependant, dans une grande majorité de cas, 
plusieurs séries de mesures sont effectuées sur un même individu (mesures répétées), invalidant 
ainsi l’hypothèse implicite d’indépendance des données . En outre, l’existence de variabilité intra-
et inter individus peut masquer des différences potentiellement significatives. 
Les modèles linéaires mixtes (LMM) sont une extension des régressions linéaires multi 
variées qui prennent en compte à la fois les effets fixes et les effets aléatoires. Les LMM
permettent également de traiter les cas de plans d’expériences avec données manquantes.
Dans cet article, les LMM sont appliqués à deux séries de données cardiovasculaires, 
puis les résultats sont comparés à ceux obtenus par ANOVA. Le premier exemple traite de 
l’analyse du rythme cardiaque de la souris après injection d’atropine et de propranolol. Les 
LMM révèlent alors un important effet aléatoire individu, dépendant du traitement
pharmacologique, et fournit une estimation précise pour chacun des facteurs expérimentaux 
significatifs. Lorsqu’une partie (20-30%) des observations est aléatoirement supprimée du jeu de 
données , le facteur « temps » perd toute significativité avec l’ANOVA, alors qu’il demeure un 
facteur significatif avec les LMM. Le deuxième exemple traite de l’analyse de la pression dans le 
cas de cœurs de souris transgéniques, lorsque ceux-ci sont isolés et placés en perfusion
coronarienne. Les LMM mettent ici en évidence un effet transgénique significatif pour les souris 
mâles, comme pour les femelles, alors que l’ANOVA ne souligne cet effet que dans le cas des 
mâles.
Dans les deux exemples traités, les LMM comparés à l’ANOVA, permettent de 
distinguer les effets fixes des effets aléatoires, offrant ainsi une étude plus rigoureuse dans le 
cas de plans d’expériences incomplets avec répétitions.
Mots clés: Modèles Linéaire Mixtes, étude de données cardiovasculaires, effet aléatoire, critère 
d’information, analyse statistique. 
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1 Introduction
In biological research, the methods generally employed to describe the data and to 
account for fixed and random effects are based on the analysis of variance (ANOVA). Fixed
effects are factors that do not vary between measurements, such as sex or transgenic strain. 
Random effects vary at each measurement point. ANOVA performs a linear regression to 
estimate the fixed effects parameters of the underlying models, and to reveal significant 
differences. Nevertheless, lack of efficient algorithms have traditionally prompted some users to 
work with balanced designs only, and to comply with such constraint, some data were simply 
withdrawn from the experimental data set. However, from a theoretical viewpoint, ANOVA does 
not require to necessarily consider balanced designs, and more recent softwares are now free of 
this constraint. More importantly, linear models assume more stringent hypothesis that do not 
match all possible applications. For instance, in a host of situations, data are obtained from a 
fixed set of subjects observed under different conditions and times (longitudinal studies). Such 
framework, referred to as repeated measures, necessarily implies correlation between
observations derived from a same subject. In general, studies are not conditioned to the 
subjects, and these latter induce on their own an unobservable random effect. The ANOVA 
model does not take into account this dimension, but only accounts for fixed effects, viewed as 
controlled factors such as sex or transgenic manipulations. The linear mixed models (LMM) have 
been proposed to circumvent these limitations, by adding random effects aimed at modelling the 
variability due to peculiarity of the observed subjects (reviewed in (10)). Originally, the method 
has been developed for balanced designs (3), then generalized to arbitrary Gaussian mixed 
models (6). Its use is now widespread thanks to the joint development of performing software 
and hardware. 
The purpose of this paper is to introduce Linear Mixed Models to cardiovascular research. 
Using two examples derived from cardiovascular context, we illustrate the extended capabilities 
of LMM over ANOVA models. The first example deals with atropine and propranolol effects on 
the mice heart rate which is known to be a highly variable parameter. The second example is an 
analysis of isolated coronary-perfused pressure of mice hearts, in order to study a transgenic 
effect.
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2 Theory
As analysis of variance models are particular cases of linear models, analysis of variance models 
with random effects are part of a more general theory on linear mixed models. In this domain, an 
abundant literature exists: aside from the “classical literature” on linear models, more recently a 
large number of books have been exclusively dedicated to linear mixed models, including 
“Variance components” from Searle et al. (12), and “Mixed-Effects models in S and S-Plus” from 
Pinheiro et al  2000 (11).
Under normal assumption, LMM’s rely on Maximum Likelihood (ML) estimating 
procedures, as it is also the case for ANOVA models, but in contrast to ANOVA, these ML 
procedures do not admit analytic solutions in general and can only be numerically solved. 
Today, statistical softwares like R, S-plus, SAS have turned these methods more accessible,
favouring their use in many scientific domains, such as genetics, psychophysiology and 
psychometry (1, 2, 5, 7, 8).
2.1 The Variance Analysis Model (ANOVA)
The usual ANOVA model aims at interpreting the response variable Y as a linear combination of 
factors, and quantifies the joint effect of each factor level (or state) according to the following 
model equation:
ijkijijkY εµ +=                 (1)
In this equation, indices i and j denote the i-th and the j-th level (or state) of factors F1  and F2
respectively, whereas index k  corresponds to the k-th repetition of the occurrence (i,j)
(k=1,…,nij). We pose n = ? i,j nij, the total number of observations. Moreover, Anova model 
assumes that eijk are n independent random variables, identically distributed with normal law, zero 
mean and s e
2 variance. In short, we can write e ~ NR
n(0,s e
2.Idn), where e is a vector from R
n with 
components eijk, and Idn is the identity matrix of R
n.
The unknown parameter ijµ  represents the expectation of ijkY , and expresses the idea that each 
combination (i,j) has a specific effect on the response Y , but does not express the possible 
individual effects, nor it expresses the interaction of F1 and F2. Then, it is necessary to expand 
each parameter µ ij into factor dependent terms as:
ijjiij γβαµµ +++=                  (2)
This new expression of ijµ  induces linear constraints on the parameters α , β  and γ . In the 
sequel of this presentation, the following arbitrary parameterization is selected:
,0,0,0 1111 ==== ii γγβα       for all i and j.                         (3)
Commonly, software outputs refer to µ as to the Intercept, which corresponds to the first state 
effects of factors F1 and F2 simultaneously. Parameters iα  and jβ  quantify the mean differential
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effects of the i–th state of factor F1 and the j–th state of factor F2, with respect to the first states 
of F1 and F2, respectively. The interaction effect between state i of F1 and state j of F2 is then 
isolated and measured with parameter ijγ .
Since the model is linear, equation (1) is often written in its matrix form:
εθ += XY                           (4)
where Y is the observation vector from Rn with components ijkY , θ  is the vector of unknown
parameters (µ , 2α ,…, Iα , 2β ,…, Jβ , 22γ ,…, IJγ ). Given also the specific parameterization 
(3), the design matrix X  is filled with 0’s and 1’s depending on which combination (i,j) does the 
observation belong to. This matrix can take on any structure in general, and the estimated 
parameter θ , solution of (4) reads
YXXX ')'(? 1
^
−= .                      (5)
This estimator, commonly referred to as the “least square estimator”, also coincides with the 
maximum likelihood estimator of θ , since ε  satisfies to the normal hypothesis.
2.2 The linear mixed model (LMM)
The framework of LMM’s, or more particularly of ANOVA models with random effects, differs 
from the framework of classical ANOVA by experimental and / or modelling contexts. For 
instance, recalling the ANOVA formalism with two factors, let us assume that factor F1 describes 
a “drug” factor that takes on three different states associated to distinct drugs, and that factor F2
represents the gender effect with only two states. These two factors are controlled, and in a 
classical ANOVA experimental set up, each animal is associated to one single observation. 
Thus, it is necessary to have n distinct animals at our disposal to realistically assume 
independence of responses. However, experiments are most often performed on a set of
individuals, each of them being observed under all different states (i.e. after each corresponding 
drug injection). Then, it becomes necessary to improve the model to take into account this 
repetition effect. It is also clear, that this subject effect can not be modelled like factors F1 and F2:
its levels are not controlled and moreover, the goal here is not to differentiate among individuals.
On the opposite, we consider all subjects as a unique sample issued from the same population, 
hence the introduction of a “subject” random effect. Then, model equation (1) becomes
ijssijjiijs uY εγβαµ +++++=                (6)
where su ( Ss ,...,1= , S  being the subject sample size) is the “unobserved” random effect
due to subject s. These effects are supposed to be independent, identically distributed with a 
zero mean Gaussian law and variance 2uσ , reflecting the idea that subjects come from the same 
population (same law), and have distinct biological parents (independence). The model assumes 
independence between effect u  and errors ε . As for (4), the new model (6) admits a matrix 
expression of the form:
Statistical Modelling of Cardiovascular Data. An Introduction to Linear Mixed Models
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εθ ++= ZUXY . (7)
The random effect vector U has dimension S , the matrix Z  of size n   x S   is in our model, 
filled with 0’s and 1’s. From the various hypotheses, we get for the variance of the observation 
Y   the following non diagonal matrix:
nu IdZZYVar 22 ')( εσσ += ,                     (8)
which depends on the two unknown variance components 2uσ and
2
εσ . The maximum likelihood
estimation of these quantities is a well-known procedure. However, in contrast to the classical
linear case, it does not lead to close form estimates in general. Instead, we must turn to numerical 
implementation of the solutions (see for instance Searle et al. (12) for a detailed study of these 
classical estimation procedures). As for the matrix X , the component ZU  can take on very 
general forms, and in particular it can be expressed as k
K
k k
UZZU ∑ == 1 , where each kU
corresponds to a particular random effect.
2.3 Model selection
This approach allows for constructing a rich class of models generated by a variety of fixed and 
random designs X and Z , respectively. A “good choice” for the pair ),( ZX  must result 
from a selection model procedure based on information criteria to be minimized. Those criteria 
rely on the log-likelihood, denoted )(ML , evaluated at θ̂  and 2σ̂ , where 2σ̂  is simply the 
vector made out of the variance components. We designate by )(Mq  the number of estimated 
parameters in the model, i.e. 2ˆdimˆdim)( σθ +=Mq .
AIC: Akaike Information Criterion 
)(2)(2 MqML +− (9)
BIC: Bayesian Information Criterion
)()ln()(2 MqnML ⋅+− (10)
Difference between these two criteria is uniquely in the penalty factor (2 versus )ln( n ). In 
practice, AIC selects models less parsimonious than BIC, whereas this latter promotes robust 
models with retained effects that are even less questionable. Finally, let us note that the 
likelihood ratio tests remain valid as far as fixed effects are concerned (test on the θ  vector 
components), but have no theoretical legitimacy at resolving presence versus absence of 
random effects.
3 Data analysis
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The utilization of LMM, as compared to ANOVA, was illustrated in the two following 
experimental set up. Both include comparative analysis of cardiovascular data obtained after 
drug injections. Such set up were conventionally analysed with ANOVA in cardiovascular
research.
3.1 In vivo study of mice heart rate 
Most mammalians have a vagal tone, mice could be an exception, as previously suggested in (9). 
Such a question was addressed by analysing the effects of two antagonists of the autonomous
nervous system on the heart rate of non anesthetized mice. 
Eighteen males C57bl/6 mice (10 to 14 wk) were housed individually for two weeks at room 
temperature before recording. A biocompatible transmitters (TA10ETA-F20, DataSciences 
International, St Paul, MN) was implanted under isofluran mixture with carbogene anaesthesia 
(1.5 vol %). Three days later, heart rate was investigated using a telemetric process (Physiotel 
Receiver RLA1020, DataSciences International, St Paul, MN) in non anaesthetized freely mo ving
animals. Recordings were made through the data acquisition system Powerlab 16 SP and Chart 4 
(ADInstruments, Australia) at a sampling frequency of 2,000 Hz. At 2:00 pm, basal ECG was 
recorded after a single IP injection of either saline, or saturating dose of atropine (1 mg/kg), or 
propranolol (1 mg/kg) or a combination of atropine and propranolol.
The response variable, RR , is the time interval separating two consecutive heart beats (RR 
interval) which have been averaged on ECG recording during five minutes. This measure was 
performed after placebo (control – C), atropine (A), propranolol (P), or propranolol + atropine 
(AP) injections.
Mice were randomly assigned in these four injection levels, but for each state not all mice enter 
the experience, leading thus to an unbalanced design. For each of these injections, the RR  were 
calculated before injection (T0), then 20, 40 and 60 minutes after injection (T20, T40 and T60, 
respectively). The working sample contains 171 measures.
3.1.1 Descriptive analysis
The measures of pharmacological autonomic blockade on the baseline heart rate are summarised 
in Table 1. This table reveals, before any statistical modelling, a strong placebo effect, the lack of 
a proper atropine tachycardia, and a pronounced slowing down of heart rate in state P. The 
combined injection of atropine and propranolol (AP) produces similar trends as in state P, but 
with smaller magnitude. Statistical modelling was performed with LMM, since we are in presence
of repeated, and thus not independent measures. The results of the analysis were compared to 
those of an ANOVA model, although in that case the statistical hypotheses fail to apply to our 
experimental set up.
3.1.2 Statistical analysis. 
The goal of this study is to model the variable to be explained RR , according to the two inputs: 
state injection (S) and time (T). Each measure is denoted STMRR , with },,,{ APPACS ∈ ,
}60,40,20,0{ TTTTT ∈  and M is the mouse label. In the course of the process, among all 
addressed models, the retained one corresponds to the smallest criterion value.
Statistical Modelling of Cardiovascular Data. An Introduction to Linear Mixed Models
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Step 1: random effect characterisation
In a first step, we consider the elementary fixed effect only due to the state injection factor S, 
,Sαµ +  with 0'' == CSα . The random effect was then formalized through five possible 
models.
We start with an ANOVA model that involves no random effect:
M 0  : =STMRR STMS εαµ ++ .
Next, our first linear mixed model introduces a mouse random effect, denoted Mu :
M M : =STMRR STMMS u εαµ +++ .
Then, we consider a more elaborate model that adds a state dependent mouse random effect 
SMu / , implicitly assumed to be independent with Mu :
M SM ! : =STMRR STMSMMS uu εαµ ++++ / .
At this point, none of the models MM or MM/S integrate in their random effect the time influence. 
So, we now propose three extended versions of MM and MM/S, namely M
T
M , M
T
SM /  and 
M
T
SMM /, , that assume isolated or joint time dependent random effects, denoted Mv  and SMv / :
M TM : =STMRR STMMMS vTu εαµ ++++ . ,
M T SM / : =STMRR STMSMSMMS vTuu εαµ +++++ // . ,
and M
T
SMM /, : =STMRR STMSMSMMMS vTuvTu εαµ ++++++ // .. .
In the last three models, all random effects are supposed to be independent, and T  is a 
functional of the time variable t . For each of these six models, the corresponding criteria were 
computed (Table 2). From these AIC and BIC values, the first LMM (MM) does not reveal a very 
strong random effect and therefore does not really outperform the simple ANOVA model (the 
two AIC’s being close one to the other). However, the MM/S model shows a clear inter-individual
mouse variability, provided it is conditioned to the injection type. The same conclusions apply 
to the specific time-dependent random effect model M T SM / , showing that time and mice random 
effects are significant only through the state injection factor. On the other hand, the two models 
M TM  and M
T
SMM /, , are not relevant. In the sequel then, only the random effects Mu , SMu /
and
SMvT /.  are retained. This structure implies not only a correlation between all measures
coming from the same mouse, but an even stronger correlation between measures coming from 
the same mouse observed at different times in a given state. If 2Mσ ,
2
/ SMσ ,
2
/ SMτ  and 
2
εσ ,
designate the variances of Mu , SMu / , SMv /  and MTSε , respectively, then, the following 
covariances hold (these four variables are supposed to be independent):
2
'' ),cov( MMTSSTM RRRR σ= , for 'SS ≠ ,
and
2
/
2
/
2
' '),cov( SMSMMMSTSTM TTRRRR τσσ ++= , for 'TT ≠ .
Similarly, the variance of each observation is
22
/
22
/
2)var( εστσσ +++= SMSMMSTM TRR .
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A simple linear time functional T  was initially tried in the model, however in practice this 
arbitrary choice needs to be confronted with more general forms. In this direction, we also 
plugged in the model several non-linear functionals of the form attT a: , with a varying. 
Actually, none of these choices outperformed the simple linear functional ( 1=a ), which was 
finally retained.
So far, the independence between random effects has been assumed. Very often though, such 
an assumption is unlikely to hold true and needs further investigation. In this example, no 
dependence between any two of the retained random effects improved the model.
Finally,  data variance fitted random effect  is:
SMSMM vTuu // .++ ,
with no correlation between random effects.
Step 2: Fixed effect characterization
After having determined a sensible random effect, we now focus on the fixed effect modelling. In 
this experimental set up, the only two explicative variables are the state injection S and the time 
T. Whereas S is clearly a factor since it is not measurable, T can impact the model either as a 
quantitative variable, or a factor. One goal of this section is to choose between these two 
possibilities. Jointly, we have to check existence of interactions between the two explicative
variables. In other words, we must select, comparing the corresponding information criteria, 
among four possible models reflecting the fixed effect:
Ø TS βαµ ++ : T  is the quantitative variable, and β  its coefficient,
Ø TT SS γβαµ +++ : same as previous with Sγ  an extra state dependent time
coefficient,
Ø TS βαµ ++ : Tβ  is the time factor effect with conventionnaly 0'0' == TTβ ,
Ø STTS γβαµ +++ : same as previous with STγ  the interaction between state and time 
factors, and 0=STγ  if '' CS =  or '0' TT =   .
The selection criteria corresponding to these four models are summarized in Table 3. First, let us 
notice that all four models outperform the models omitting time as a fixed effect. Furthermore, we 
infer from Table 3, that the time variable behaves as a factor in the fixed effect, without
significant interaction with drug injection effect.
This model generates seven fixed effect parameters. Looking at the estimated values and at their 
associated p-values (not reported here), ''AS =α  and '60'TT =β  can be neglected, confirming in 
that, the experimental results of Table 1. Eventually, the tailored model comprises only five 
highly relevant parameters to describe the fixed effect (Table 4), and four parameters to describe 
the variance (Table 5), with a corresponding AIC and BIC equal to 1344.5 and 1372.8
respectively.
At last, for comparison purpose with the observed values of Table 1, it is possible to compute 
the fitted values and associated standard deviations, using the estimates reported in Tables 4 
and 5. We give these results in Table 6.
There is a pronounced placebo effect at time T20 and T40 (p<0.001). Atropine injection has the 
same effect as placebo on the mean RR, as states ’C’ and ’A’ can be confounded at all 
Statistical Modelling of Cardiovascular Data. An Introduction to Linear Mixed Models
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experimental times. Propranolol injection, respectively its association with atropine, produces a 
strong RR enlargement of 33.78 ms, and 25.20 ms respectively, with no interaction with 
experimental times. Within the 60 minutes duration of this experiment, no propranolol effect 
attenuation was significantly evidenced.
Comments
Let us first stress that reproducing analysis of step 2, but ignoring random effects (i.e.
withdrawing step 1), leads to similar fixed effect conclusions, except that the time factor '60'TT =β
becomes significant with ANOVA. These resembling results between ANOVA and LMM 
approaches are quite usual, mainly when the model’s fixed effects are highly significant, as it is 
the case here. It means that fixed effects are robust with respect to the model covariance
structure. However, when suppressing randomly observations from the data set (20 to 30 %), the 
time factor '60'TT =β  of ANOVA model becomes non significant, whereas all other parameters of 
the fixed effect remain significant. Playing with the same data suppression, LMM remains robust 
with respect to all its significant parameters.
Regarding the error modelling of this ANOVA model, the dispersion parameter 2εσ  is estimated
to be 347, and it can be related to a combination of all partial variance components, whose 
estimates are reported in Table 5. Then, it becomes clear that most of the data variability has 
been explained by the random effects modelling. As for the fixed effects, each random
component estimates deserves a thorough  interpretation. In this particular study for instance, 
the relatively large estimated value for SM /σ , indicates that the four injection types induce a 
strong intra-individual variability.
From an AIC viewpoint, such fixed effect model (ANOVA) would increase AIC by 148 (AIC = 
1492.4), as compared to the linear mixed model (AIC = 1344.5). On the other hand, a null model 
(where all data are considered independent and identically distributed) has an AIC equal to 1570, 
which is 88 larger (and thus worse) than the  AIC of the sole fixed effect model (AIC = 1492.4). 
The above differences (148 versus 88) support the claim that in LMM, the overall gain comes 
rather from a proper random effect modelling than from the fixed effect modelling. This assertion
is naturally sustained when the model accounts for the random effects only. AIC of such a 
model (equal to 1381.5), conveys an improvement over the null model, that surpasses the 
improvement induced by the ANOVA model.
To conclude, such a study illustrates that modelling properly the random effects brings valuable 
information that does not question the results obtained with an accurate fixed effect modelling, 
but rather complements knowledge about the experimental set up. Note also that in this 
particular example, ANOVA is basically an erroneous model.
14
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3.2  Isolated coronary-perfused hearts in transgenic mice
A transgenic strain of mouse was generated to study the effects of myocardial aldosterone 
production on endothelium-independent coronary reactivity. The construct includes a cardiac 
specific promotor. 
Nine Adult transgenic (four males and five females) and ten wild-type (five males and five 
females) FVB mice (8-10 weeks old,) were anaesthetised (pentobarbital sodium, 0.1ml/100g) and 
heparinised (heparin sodium, 100 IU/100g) using IP injection. Hearts were rapidly excised, 
cannulated, and retrocoronary perfused at constant flow with a Krebs Henseleit buffer
equilibrated with 95% O2 and 5% CO2 (pH 7.4, 37
oC). During a 20 minutes equilibration period, 
coronary flow was adjusted to achieve a coronary perfusion pressure of 60±5 mmHg as used 
previously. A coronary perfusion pressure of 60mmHg produced optimal vasodilator responses 
and preliminary experiments demonstrated that left ventricular function was normal at this level. 
The coronary perfusion pressure (CPP) was measured via a pressure transducer and data 
recorded on a MacLab/8s system (ADI, Australia). A left ventricular balloon was not used as it 
impairs vasodilator responses in some animals from all strains and introduces additional 
variability. Bolus (10µl) of sodium nitroprusside (SNP, 10 nmol/L - 1 mmol/L) were injected just 
above the aortic cannula into the flow (~1% of the flow causing no change in coronary perfusion 
pressure), with sufficient time allowed between agents to allow recovery of basal coronary 
perfusion pressure. 
The response variable PP , is the coronary perfusion pressure in response to six SNP 
concentration doses (in Mol/l): ,10 81
−=d ,10 72
−=d ,10 63
−=d ,10 54
−=d ,10 45
−=d
3
6 10
−=d . This measure is performed in order to assess both transgenic and gender effects 
and includes 114 determinations.
3.2.1 Statistical analysis
The effects of SNP on coronary pressure were summarized in table 7. Like for the previous 
experiment, a satisfactory Linear Mixed Model was elaborated using Information Criteria to 
orient the selection model. For the sake of concision, details of steps 1 and 2 that led to
characterize random and fixed effects, are omitted. Rather, the retained model is commented with 
emphasis on its improvements over more standard procedures (e.g. ANOVA with repeated 
measures).
As far as random effect was concerned, only a subject (mouse) random effect Mu , a dose 
dependent mouse random effect MDν. , and their correlation, were significant. It is worth 
noticing that neither gender G, nor transgenesis T produce significant random effects on PP .
Regarding fixed effects, the roles of the two factors G and T have to be formalized, and d  to be 
identified as a factor or a quantitative variable in the model. After this, relevance of the 
interactions between these inputs needs to be established. 
After all these steps, the model reads
TGdMPP  = TGdMMMTTG DuDD ενββγµ ++++++ ... ,
where the functional 




>
≤=→
−−
−
69
10
6
10),10/(log
,10,0
)(:
dd
d
dDdD
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transforms the quantitative variable dose jd  into a new discrete log-dose variable 00 =D  (for 
321 ,, ddd ), 41 =D  (for 4d ), 52 =D  (for 5d ),  and 63 =D  (for 6d ). Note that in this
model, all injection doses less than 610−  mol/l, can be confounded and their effect neglected.
Furthermore, in this expression:
Ø µ  is the intercept corresponding to wild type female mice with an injection dose less
than 610− ;
Ø TGγ  is the interaction between gender (G) and transgenesis (T), and in this particular 
case, only the interaction between Transgenic and Male is significant leading to 
0'','' ≠== MaleGTransgenicTγ ;
Ø β   is the coefficient that expresses the overall linear effect of D  on the model;
Ø Tβ  is the coefficient that expresses the transgenesis dependent linear effect of D , with 
conventionally 0'' == WildTβ  ; 
Ø the mouse random effect Mu  has variance 
2
Mσ , and the dose dependent mouse random 
effect Mν  has variance 
2
Mτ . Given a mouse M , the correlation between Mu  and Mν
is denoted ρ  and is unknown.
Ø The variance of residual error TGdMε , is denoted εσ
This model comprises only four prevailing parameters to describe the fixed effect (estimates 
given in Table 8), and four parameters to describe the variance (component estimates in Table 9). 
To be more explicit, we give for each mice group the corresponding model equation with the 
associated fitted values. We expand these final results in Table 10.
3.2.2 Comments
When these results were compared to the null  model (for which AIC = 844.6), the LMM shows 
an overall gain of 125, originated from both the effective random effect modelling and from the 
fixed effect modelling (ANOVA model). A model that only accounts for the random effect shows 
an AIC gain of 87, whereas ANOVA model shows an AIC gain of 110. In contrast to the first 
study, it is mainly the fixed effect characterization that improves model performances. From a 
physiological viewpoint, this is quite coherent with the modus operandi that suppresses the 
natural mice heterogeneity when isolating the heart. Nevertheless, a random effect exists, and 
the variance components estimates clearly show that the variability increases with the dose, but 
does not depend on gender or on transgenesis.
From a statistical viewpoint though, that means that ignoring random effects and retaining only 
this fixed effect model would have led to the same estimated parameters and the same 
conclusions, albeit the corresponding fixed model is theoretically not valid in the presence of 
repeated measures. However and obviously, this a posteriori “fortunous” conclusion can only 
be inferred after having properly and jointly characterized the fixed and random effect.
Disregarding random effects in the modelling may lead to miss significant parameters, or 
conversely to propose an over-dimensioned model. 
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4 Discussion
Many statistical methods of analysis have been previously developed under balanced 
design assumption for the analysis of repeated-measures studies. At present, it’s clear that in 
order to develop more effective and more powerful observations studies, mixed models methods 
should be more systematically used. The above examples illustrate how ANOVA should be 
considered inadequate, when the study design includes incomplete or unbalanced observations. 
Linear models that merge together random effects and systematic errors are at the origin of many 
significance tests, including the most commonly used test, namely ANOVA. In linear models, the 
fixed effects were usually presented as curves, means and clusters, while the dispersion 
parameter was ascribed to randomness. One important limitation of linear models is that they do 
not theoretically account for repeated measures, even if, when the design is balanced, the fixed 
effect estimation may be numerically acceptable. But, for unbalanced or incomplete designs with 
repeated measures, linear models, such as the traditional ANOVA, definitely have to be avoided 
in favour  of mixed models. Mixed models are specifically built for non independent measures like 
repeated measures, and hold for any design structure. In physiological settings for instance, 
situations of unreadable recordings, or incomplete data series due to missing samples, are very 
common and should naturally resort to mixed models. Moreover, mixed models allow to estimate 
the treatment (or drug) effect under a large range of variance structures, while ANOVA requiring
sphericity conditions (an assumption which is rarely valid in physiological settings) necessitates 
numerous and debatable correction schemes. Finally, mixed models produce regression 
coefficients and also predictors that, for each subject, may be either fixed or variable-dependent.
Mixed model methods of analysis have been applied in various setting of experimental
research, including the evaluation of dissolution profiles (1), statistical measurement of foetal 
growth (5), the study of fragile X syndrome (7), or the variability of blood pressure (8), to cite but 
a few. For example, it was also used by Bagella et al. (2) in psychophysiology, to analyze the 
electromyographic response of the left brow region to various kind of musical stimuli. The 
experimental set up includes a large number of missing data which were analysed separately. 
Data were extremely scattered with a high variance that increases with the mean (as usual in 
physiology), a temporal autocorrelation, and conditions of sphericity that were not satisfied. 
Using the entire electromyographic data points, a comparative study evidenced the robustness 
of the mixed model as compared to the ANOVA model, when randomly deleting observations
from the data set. The present cardiovascular studies yield similar conclusions with respect to 
data suppression. Various softwares are currently available, that can efficiently fit most of mixed 
models (reviewed in (1, 4, 10)).
The studies conducted here were performed with R Toolbox, a freeware software that
can be dowloaded from the Comprehensive R Archive Network at http://cran.r-project.org.
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Table 1 : Mean of RR  (in ms) over the mice set, for each state injection and each measurement
time: mean (SE) [corresponding unit number]
T0 (n=50) T20 (n=40) T40 (n=41) T60 (n=40)
C
114.4 (17.7)
[n=50]
95.9   (7.8)
[n=12]
98.6    (7.4)
[n=13]
102.7 (8.7)
[n=12]
A
92.8   (6.0)
[n=10]
96.9    (9.4)
[n=10]
100.0 (9.5)
[n=10]
P
131.3 (25.8)
[n=9]
139.3  (33.3)
[n=9]
146.6(41.3)
         [n=9]
AP
123.0 (22.0)
[n=9]
128.0  (15.4)
[n=9]
130.2  (12.8)
[n=9]
Table 2. Akaike Information. Criterion corresponding to the five studied random effect models
Model M 0 M M M SM / M
T
M M
T
SM / M
T
SMM /,
AIC 1500.9 1490.9 1375.1 1486.9 1366.8 1368.0
BIC 1516.6 1509.7 1397.1 1508.9 1392.0 1396.3
Table 3 Akaike Information Criterion corresponding to the four studied fixed effect models
Fixed
effect
TS βαµ ++ TT SS γβαµ +++ TS βαµ ++ STTS γβαµ +++
AIC 1361.2 1359.9 1347.1 1356.2
BIC 1389.4 1397.6 1381.6 1409.6
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Table 4. Estimated values with corresponding p-values of the final five significant fixed effect 
parameters. Estimated values are relative to the intercept value
Estimated value p
µ 108.06 < 410−
'20'TT =β -10.02 < 410−
'40'TT =β -4.95 2.5 310−
''PS =α 33.78 < 410−
'' APS =α 25.20 310−
Table 5. Estimated variance components associated to the six random parameters retained in 
the final linear mixed model
Variance comp onents
Mσ SM /σ SM /τ εσ
Estimates 0.54 15.88 4.39 7.34
Table 6: Fitted values (SD) corresponding to all possible crossings between significant states 
and times
T0 T20 T40 T60
Control or Atropine 108.06  (2.92) 98.04    (3.35) 103.12  (3.28) 108.06  (2.92)
Propranolol - 131.82  (6.64) 136.90  (6.72) 141.85  (6.67)
Atropine + Propranolol - 123.24  (6.64) 128.32  (6.72) 133.27  (6.69)
Statistical Modelling of Cardiovascular Data. An Introduction to Linear Mixed Models
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Table 7: Coronary perfusion pressure ( PP ) in mm Hg. Mean(SE). Effects of sodium
nitroprusside bolus injection (SNP in Mol/l) CPP (PP ) averaged over the mice set, at each 
factor and each measurement dose. Units are in mm Hg.
SNP
810−
710− 610− 510− 410− 310−
Wild type female 4.61 (1.81) 5.95 (1.76) 7.33 (1.04) 20.19 (4.81) 24.13 (4.01) 25.34 (3.00)
Wild type male 7.50 (2.73) 4.43 (1.82) 7.94 (1.99) 17.31 (2.10) 25.95 (2.48) 24.02 (2.48)
Transgenic female 3.71 (1.88) 8.50 (5.04) 8.03 (1.89) 8.03 (3.37) 15.41 (2.62) 14.78 (8.70)
Transgenic male 1.91 (2.08) -0.77 (2.22) 2.27 (1.71) 6.43 (2.18) 6.66 (3.24) 8.70 (2.62)
Table 8: Estimated values with corresponding p-values of the final four significant fixed effect 
parameters. Estimated values are relative to the Intercept value µ
Table 9: Estimated variance components associated to the four random parameters retained in 
the final linear mixed model
Variance components Mσ Mτ ρ εσ
Estimates 0.71 0.85 0.7 4.68
Estimated value p
µ (control) 6.39 < 1e-4
''',' MaleGTransgenicT ==γ -5.33 2.8e-3
β 3.29 < 1e-4
''TransgenicT =β -1.96 2e-4
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Table 10: Model equations and fitted values describing each one of the eight mice groups
Dose D
Group
0D  (
610−≤d ) 1D
( 510−=d )
2D
( 410−=d )
3D
( 310−=d )
Wild type 6.39 + 3.29 jD
female 6.39 19.54 22.83 26.12
Wild type 6.39 + 3.29 jD
male 6.39 19.54 22.83 26.12
Transgenic 6.39 + (3.29 – 1.96) jD
female 6.39 11.71 13.04 14.37
Transgenic 6.39 – 5.33 (6.39 – 5.33) + (3.29 – 1.96) jD
male = 1.065 6.38 7.71 9.04
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